{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-047368","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2024-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.723363+00:00","generated_at":"2026-06-03T22:57:23.134839+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NRx Pharmaceuticals increases ATM offering to $4.85M after $1M already sold","bullets":["Maximum aggregate offering price raised to $4,852,909 under existing August 2023 ATM agreement with H.C. Wainwright.","Prior to this filing, $1.0 million in common stock had been sold under the same agreement.","Prospectus supplement filed April 15, 2024 to register the additional shares.","No specific use of proceeds disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-047368","json":"https://secwatch.observer/filing/0001104659-24-047368.json","markdown":"https://secwatch.observer/filing/0001104659-24-047368.md","text":"https://secwatch.observer/filing/0001104659-24-047368.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000110465924047368/0001104659-24-047368-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000110465924047368/tm2411778d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:57:23.134839+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}